Aclaris Therapeutics, Inc. Quarterly Contract with Customer, Liability, Current in USD from Q3 2024 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Summary
Aclaris Therapeutics, Inc. quarterly Contract with Customer, Liability, Current history and growth rate from Q3 2024 to Q2 2025.
  • Aclaris Therapeutics, Inc. Contract with Customer, Liability, Current for the quarter ending June 30, 2025 was $3.91M.
Contract with Customer, Liability, Current, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q2 2025 $3.91M Jun 30, 2025 10-Q 2025-08-07
Q1 2025 $3.89M Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $3.89M Dec 31, 2024 10-Q 2025-08-07
Q3 2024 $3.77M Sep 30, 2024 10-Q 2024-11-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.